1. Home
  2. Live Updates
  3. Ioscience

Page 25 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Gufic Biosciences launches India's first indigenous Botulinum Toxin injection Zarbot

Developed and manufactured in collaboration with US-based Prime Bio ....

Balaram Singh , Dirk Dressler , Gufic Biosciences , Centre Of Excellence , Mumbai Based Gufic Biosciences , Botulinum Toxin Type , Botulinum Toxin ,

Lexaria Bioscience Corp.: Lexaria Receives First Granted Patent in Canada

KELOWNA, BC / ACCESSWIRE / December 29, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce its ....

British Columbia , George Jurcic , Exchange Commission , Lexaria Bioscience Corp View , Company Or Lexaria , Lexaria Bioscience Corp , Drug Administration , Lexaria Bioscience ,

Lexaria Bioscience Corp.: Lexaria's DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels

KELOWNA, BC / ACCESSWIRE / December 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it ....

Chris Bunka , George Jurcic , Exchange Commission , Lexaria Bioscience Corp , Lexaria Bioscience Corp View , Company Or Lexaria , Drug Administration , Lexaria Bioscience , Although Lexaria , Bioscience Corp ,

Avidity Biosciences Ups Public Offering Size

San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the p ....

Avidity Biosciences ,

Hyundai Bioscience: Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periodsA new standard of care, more convenient than docetaxel, is suggestedHyundai Bioscience to enter clinical trial on pancreatic ....

Soult Ukpyolsi , South Korea , Lee Hwa Jeong , Peter Koo , Jin Geun , Yale University Medical School , Ewha Womans University On , Ewha Womans University , Drug Administration , Human Research Ethics Commission , Hyundai Bioscience Bio Division , Park Kwang Sik , Hyundai Bioscience , Jin Geun Woo , Sekisui Medical , Global Bio Conference ,